Kura Oncology Inc at JMP Securities Life Sciences Conference Transcript
Excellent. So good morning, everyone, and welcome to the second day of the JMP Securities Life Science Conference. It's my pleasure to introduce Kura Oncology, a physician-based biopharmaceutical company presenting for the company's Troy Wilson, President and CEO. Welcome Troy.
Thank you.
As I've said to many other companies who get on the stage with me here, I don't know who's in the audience and I don't know who's hitting the replay button, whether they know the Kura story or not. If you could, in three to five minutes, just give us an overview of Kura Oncology.
Sure. Yeah. So thank you for the invitation to come to New York and to attend the conference and to give an overview and answer questions. So as the name would suggest, at Kura Oncology, we're focused on the development of targeted therapies for the treatment of cancer, both solid
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |